Shares of SMITHS GRP PLC/S (OTCMKTS:SMGZY) have received a consensus recommendation of “Hold” from the seven research firms that are presently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, three have given a hold rating and one has given a buy rating to the company.
Several research firms recently issued reports on SMGZY. JPMorgan Chase & Co. restated a “neutral” rating on shares of SMITHS GRP PLC/S in a research report on Friday, September 21st. Goldman Sachs Group restated a “neutral” rating on shares of SMITHS GRP PLC/S in a research report on Thursday, October 4th. Zacks Investment Research upgraded SMITHS GRP PLC/S from a “sell” rating to a “hold” rating in a research report on Wednesday. Bank of America restated an “underperform” rating on shares of SMITHS GRP PLC/S in a research report on Tuesday. Finally, Royal Bank of Canada lowered SMITHS GRP PLC/S from an “outperform” rating to an “underperform” rating in a research report on Tuesday, November 20th.
SMGZY opened at $18.86 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.56 and a current ratio of 2.04. SMITHS GRP PLC/S has a 1 year low of $16.26 and a 1 year high of $24.42. The company has a market cap of $7.35 billion, a P/E ratio of 15.59, a P/E/G ratio of 2.55 and a beta of 0.83.
About SMITHS GRP PLC/S
Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.
Featured Story: What does earnings per share mean?
Receive News & Ratings for SMITHS GRP PLC/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SMITHS GRP PLC/S and related companies with MarketBeat.com's FREE daily email newsletter.